Medicare

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business HighlightsExagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

Delivered record full-year total revenue and AVISE CTD average selling priceImproved full-year adjusted EBITDA loss and cash use by over…

2 months ago
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsBrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year…

2 months ago
Milliman MedInsight Launches Comprehensive Risk Adjustment Platform for Enhanced PerformanceMilliman MedInsight Launches Comprehensive Risk Adjustment Platform for Enhanced Performance

Milliman MedInsight Launches Comprehensive Risk Adjustment Platform for Enhanced Performance

New Risk Adjustment Platform boosts accuracy and efficiency, enhancing patient outcomes, planperformance, and revenue SEATTLE, March 10, 2025 /PRNewswire/ -- Milliman…

2 months ago
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AADDupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…

2 months ago
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AADPress Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…

2 months ago
Obesity Care Week 2025 Concludes with a Global Commitment to CareObesity Care Week 2025 Concludes with a Global Commitment to Care

Obesity Care Week 2025 Concludes with a Global Commitment to Care

TAMPA, Fla., March 7, 2025 /PRNewswire/ -- As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters…

2 months ago
Soda Health partners with Southeastern Grocers to deliver smarter health and nutrition benefits to neighbors across SoutheastSoda Health partners with Southeastern Grocers to deliver smarter health and nutrition benefits to neighbors across Southeast

Soda Health partners with Southeastern Grocers to deliver smarter health and nutrition benefits to neighbors across Southeast

The partnership enables Medicaid, Medicare and other health insurance members to redeem benefits for healthy food and everyday health care…

2 months ago
IntegriChain Hosts Revenue Analytics Collaborative SummitIntegriChain Hosts Revenue Analytics Collaborative Summit

IntegriChain Hosts Revenue Analytics Collaborative Summit

Policy, Pricing, and Reimbursement Expert Jeff Baab to Keynote on Industry's Significant Pressures Executive Fireside Chat on Industry Risk Features…

2 months ago
Wellvana acquires CVS Health’s MSSP businessWellvana acquires CVS Health’s MSSP business

Wellvana acquires CVS Health’s MSSP business

With latest transaction, Wellvana supports primary care providers across 40 states, serving approximately 1 million patients. NASHVILLE, Tenn., and WOONSOCKET,…

2 months ago
Optellum and Volpara Health Announce Agreement for Lung & Breast Cancer CareOptellum and Volpara Health Announce Agreement for Lung & Breast Cancer Care

Optellum and Volpara Health Announce Agreement for Lung & Breast Cancer Care

Collaboration brings together leading lung and breast imaging expertise to advance AI-driven cancer detection and early intervention. HOUSTON, March 4,…

2 months ago